Dimensional Fund Advisors’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-874,166
| Closed | -$7.97M | – | 3335 |
|
|
2025
Q2 | $7.97M | Buy |
874,166
+392,389
| +81% | +$2.89M | ﹤0.01% | 2357 |
|
|
2025
Q1 | $3.83M | Sell |
481,777
-3,578
| -0.7% | -$26.2K | ﹤0.01% | 2574 |
|
|
2024
Q4 | $2.64M | Sell |
485,355
-3,979
| -0.8% | -$24.3K | ﹤0.01% | 2724 |
|
|
2024
Q3 | $3.53M | Sell |
489,334
-20,028
| -4% | -$183K | ﹤0.01% | 2631 |
|
|
2024
Q2 | $5.53M | Sell |
509,362
-416,216
| -45% | -$5.33M | ﹤0.01% | 2465 |
|
|
2024
Q1 | $17.3M | Sell |
925,578
-42,107
| -4% | -$971K | ﹤0.01% | 2065 |
|
|
2023
Q4 | $21M | Sell |
967,685
-359,906
| -27% | -$7.13M | 0.01% | 1963 |
|
|
2023
Q3 | $27.3M | Sell |
1,327,591
-388,677
| -23% | -$11.2M | 0.01% | 1750 |
|
|
2023
Q2 | $80.7M | Buy |
1,716,268
+61,568
| +4% | +$3.06M | 0.03% | 990 |
|
|
2023
Q1 | $69.4M | Buy |
1,654,700
+335,966
| +25% | +$14.4M | 0.02% | 1083 |
|
|
2022
Q4 | $50.3K | Buy |
1,318,734
+242,969
| +23% | +$9.28M | 0.01% | 1303 |
|
|
2022
Q3 | $42.1M | Buy |
1,075,765
+422,868
| +65% | +$16.3M | 0.02% | 1365 |
|
|
2022
Q2 | $21.1M | Buy |
652,897
+481,867
| +282% | +$16.2M | 0.01% | 1828 |
|
|
2022
Q1 | $5.66M | Sell |
171,030
-13,655
| -7% | -$513K | ﹤0.01% | 2498 |
|
|
2021
Q4 | $7.86M | Sell |
184,685
-20,181
| -10% | -$845K | ﹤0.01% | 2400 |
|
|
2021
Q3 | $9.08M | Sell |
204,866
-167,445
| -45% | -$7.68M | ﹤0.01% | 2375 |
|
|
2021
Q2 | $21.1M | Buy |
372,311
+211,539
| +132% | +$15M | 0.01% | 2024 |
|
|
2021
Q1 | $12M | Sell |
160,772
-32,990
| -17% | -$2.7M | ﹤0.01% | 2251 |
|
|
2020
Q4 | $16.8M | Sell |
193,762
-13,156
| -6% | -$970K | 0.01% | 2068 |
|
|
2020
Q3 | $12.6M | Buy |
206,918
+77,472
| +60% | +$3.93M | 0.01% | 2082 |
|
|
2020
Q2 | $5.38M | Buy |
129,446
+7,097
| +6% | +$258K | ﹤0.01% | 2458 |
|
|
2020
Q1 | $3.52M | Sell |
122,349
-8,095
| -6% | -$469K | ﹤0.01% | 2531 |
|
|
2019
Q4 | $9.42M | Buy |
130,444
+5,329
| +4% | +$656K | ﹤0.01% | 2372 |
|
|
2019
Q3 | $17.6M | Buy |
125,115
+3,118
| +3% | +$522K | 0.01% | 2088 |
|
|
2019
Q2 | $22.3M | Buy |
121,997
+2,775
| +2% | +$474K | 0.01% | 1985 |
|
|
2019
Q1 | $19M | Buy |
119,222
+10,168
| +9% | +$1.47M | 0.01% | 2085 |
|
|
2018
Q4 | $10.4M | Buy |
109,054
+31,571
| +41% | +$3.61M | ﹤0.01% | 2322 |
|
|
2018
Q3 | $10.9M | Buy |
77,483
+21,129
| +37% | +$3.26M | ﹤0.01% | 2400 |
|
|
2018
Q2 | $8.82M | Buy |
56,354
+9,992
| +22% | +$1.57M | ﹤0.01% | 2478 |
|
|
2018
Q1 | $7.47M | Buy |
46,362
+17,044
| +58% | +$2.89M | ﹤0.01% | 2479 |
|
|
2017
Q4 | $4.83M | Buy |
+29,318
| New | +$2.84M | ﹤0.01% | 2633 |
|
Other funds holding SAGE
IA
HNB